Are drug prices really too high, as President Trump implies? Robert Zirkelbach, Executive Vice President of Public Affairs for Pharmaceutical Research and Manufacturers of America (PhRMA), and Steven Pearson, Founder and President of the Institute for Clinical and Economic Review (ICER), join host John Barkett to discuss whether the prices we pay for prescription drugs represent the value those drugs provide and what could be done to possibly lower prescription drug prices on The Business of Health Care.
This Week in Business
Panel Discussion: Are Current Prescription Drug Pricings Fair?
Are drug prices really too high, as President Tru…
November 1, 2017
• 53 min listen
Are drug prices really too high, as President Tru…
Subscribe wherever you listen to your podcasts.
Comments
New This Week
Building Brain Capital: Why Early Childhood Education Shapes the Future Workforce and Economy
Experts from the Wharton Neuroscience Initiative and Masterminds Education explain why fostering adaptability early on generates lifelong returns, especially in the age of AI.
What I’ve Learned: Kenneth Shropshire
In a wide-ranging conversation with Wharton Dean Erika James, Kenneth Shropshire reflects on his unconventional path to academia and how the business of sports has evolved over his career.
Podcast
When Food Safety Becomes the Family’s Responsibility
Corinne Low, Wharton associate professor of business economics and public policy, explains why food safety is a public good, and what happens when government oversight weakens and families are left to pick up the slack.
